| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |